Studies have also shown that vitamin E inhibited hepatic TGF-β expression, which helped to lessen steatosis, inflammation, and fibrosis in patients with NAFLD, which indicated that Vitamin E is a potent antioxidant with promising potential for NAFLD treatment [99]. The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatotic liver disease.